Clinical Trial Detail

NCT ID NCT03175432
Title Study of BEvacizumab in Combination With ATezolizumab in Patients With Untreated Melanoma Brain Metastases (BEAT-MBM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Atezolizumab + Bevacizumab

Age Groups: adult senior

No variant requirements are available.